Transaction · 0001683168-25-000218

IWAKI YUICHI

IWAKI YUICHI, PRES, reported a transaction classified as grant at MEDICINOVA INC involving 400000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 400000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code APRES
MNOVMEDICINOVA INC
Filing timeJan 10
Trade dateJan 07, 2025
Filing · SECView on SEC
InsiderProfile
% of reported position tradedUnavailableNot calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

MNOV price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MNOV since 2025-01-10Filed 625 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001683168-25-000218
Employee Stock Option (Right to Buy)
Transaction date
Jan 07, 2025
Filed Jan 10, 2025, 09:00 PM · 3d delay
Shares
400k sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
400k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction Direct Ownership Large Holdings Increase
-10score
Filing-only score

-10

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

President and CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    On January 18, 2024, the reporting person was granted an option to purchase 400,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal ye…

Original filing · 0001683168-25-000218
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MNOV